ABT — Abbott Laboratories
$108.52
+$1.27 (+1.18%)
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.
Market Cap
$187.95B
Forward P/E
18.3x
52-Week Range
N/A
ABT Price History
Revenue vs. Net Income
$44.3B
Revenue · FY2025
Annual. Net margin is shown under each year.
Free Cash Flow
$7.4B
FCF · FY2025
Annual. FCF margin is shown under each year.
Return on Capital Employed (ROCE)
12.8%
ROCE · FY2025
Annual. Green above 0%, red below. Dashed line marks the 15% compounder threshold.
Total Assets vs. Total Liabilities
2.5x
Assets ÷ liabilities · FY2025
Annual. What the company owns against what it owes. Assets ÷ liabilities is shown under each year.
CapEx as % of Revenue
4.9%
CapEx · FY2025
Annual. Green at or under the 5% maximum target, red above it.
Shares Outstanding
+0.1%
Dilution · FY2025
Annual diluted shares. Under each year: the change on the previous year (green = buyback, amber = dilution).
